mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors

Scientific Reports
Tingting WuYong Zhao

Abstract

CD11b(+) Gr1(+) myeloid-derived suppressor cells (MDSCs) play critical roles in controlling the processes of tumors, infections, autoimmunity and graft rejection. Immunosuppressive drug rapamycin (RPM), targeting on the key cellular metabolism molecule mTOR, is currently used in clinics to treat patients with allo-grafts, autoimmune diseases and tumors. However, the effect of RPM on MDSCs has not been studied. RPM significantly decreases the cell number and the immunosuppressive ability on T cells of CD11b(+) Ly6C(high) monocytic MDSCs (M-MDSCs) in both allo-grafts-transplanted and tumor-bearing mice respectively. Mice with a myeloid-specific deletion of mTOR have poor M-MDSCs after grafting with allo-skin tissue or a tumor. Grafting of allo-skin or tumors significantly activates glycolysis pathways in myeloid precursor cells in bone marrow, which is inhibited by RPM or mTOR deletion. 2-deoxyglucose (2-DG), an inhibitor of the glycolytic pathway, inhibits M-MDSC differentiation from precursors, while enhancing glycolysis by metformin significantly rescues the RPM-caused deficiency of M-MDSCs. Therefore, we offer evidence supporting that mTOR is an intrinsic factor essential for the differentiation and immunosuppressive function...Continue Reading

References

Nov 17, 1967·Biochemical and Biophysical Research Communications·T TanakaH Morimura
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B AlmandD I Gabrilovich
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Jan 5, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alessandra MazzoniDavid M Segal
Apr 4, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Tian-Yu YangYong Zhao
Sep 2, 2005·Nature·Steve E CalvanoUNKNOWN Inflamm and Host Response to Injury Large Scale Collab. Res. Program
Oct 13, 2005·Diabetes, Obesity & Metabolism·Mark O Goodarzi, Michael Bryer-Ash
Apr 11, 2006·Molecular Cell·Dos D SarbassovDavid M Sabatini
Aug 22, 2006·Current Biology : CB·Maria A FriasDavid M Sabatini
Jan 25, 2007·The EMBO Journal·Richard FoxStephen M Schwartz
Jul 3, 2007·Nature Medicine·Srinivas NagarajDmitry I Gabrilovich
Apr 1, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Ramesh SaeediMichael F Allard
Jun 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anne-Sophie DugastBernard Vanhove
Oct 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Je-In YounDmitry I Gabrilovich
Oct 14, 2008·Immunity·Thomas WeichhartMarcus D Säemann
Dec 26, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hequan LiXuetao Cao
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
May 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Susanna MandruzzatoPaola Zanovello
Aug 18, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·V De WildeA Le Moine
Oct 1, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M D SäemannT Weichhart
Mar 7, 1927·The Journal of General Physiology·O WarburgE Negelein
Feb 23, 2010·Current Opinion in Immunology·Elisa PeranzoniVincenzo Bronte
Sep 2, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael HaidingerThomas Weichhart
Nov 12, 2010·Trends in Immunology·Thomas Condamine, Dmitry I Gabrilovich
Dec 1, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S BrouardA Sanchez-Fueyo
Aug 2, 2011·Current Opinion in Immunology·Jason R LeesJonathan S Bromberg
Aug 5, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Babak BabanAndrew L Mellor
Oct 25, 2011·Annual Review of Pharmacology and Toxicology·Ken InokiKun-Liang Guan
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
Jun 15, 2012·American Journal of Physiology. Renal Physiology·A H KirschK Eller
Aug 15, 2012·Immunological Reviews·Adam T Waickman, Jonathan D Powell
Oct 10, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tingting WuYong Zhao
Jul 25, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hui ChenYong Zhao
Nov 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yanyan WangHongbo Chi

❮ Previous
Next ❯

Citations

Jun 2, 2016·Journal of Translational Medicine·Giovanni StalloneGiuseppe Grandaliano
Aug 4, 2018·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Seiji MabuchiTadashi Kimura
Sep 6, 2018·International Journal of Cancer. Journal International Du Cancer·Laurent BeziaudOlivier Adotévi
Jan 31, 2018·Journal of Translational Medicine·Weitao ZhangMing Xu
May 6, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Fan YangYong Zhao
Jun 9, 2019·International Journal of Molecular Sciences·Giovanni StalloneGiuseppe Grandaliano
Dec 1, 2017·Transplantation·Joseph R ScaleaJonathan S Bromberg
Nov 15, 2018·Frontiers in Immunology·Kim Ohl, Klaus Tenbrock
Mar 22, 2019·Frontiers in Immunology·Jordi OchandoEstela Paz-Artal
Jul 31, 2018·Journal of Immunology Research·Fan YangYong Zhao
May 20, 2020·Frontiers in Immunology·María Iglesias-EscuderoMarcos López-Hoyos
Apr 18, 2018·Frontiers in Immunology·Yakir GuriJason Roszik
Feb 21, 2019·Innate Immunity·Young Suk LeeJoseph R Scalea
Jun 2, 2018·Cancer Immunology, Immunotherapy : CII·Yijun LiuHong Qin
Aug 15, 2018·International Journal of Molecular Sciences·Tsukasa Nakamura, Hidetaka Ushigome
Mar 3, 2019·International Journal of Molecular Sciences·Lisha Xiang, Daniele M Gilkes
Oct 9, 2020·International Journal of Molecular Sciences·Haiyan DaiJie Ma
Apr 15, 2016·Cancer Immunology Research·Ellen C MooreClint T Allen
Feb 14, 2021·Cell Death & Disease·Jiawei LiRuiming Rong
Feb 11, 2021·Cells·Seiji MabuchiNaoko Komura
Jan 9, 2021·Journal of Experimental & Clinical Cancer Research : CR·Huanhuan HuangChao Ni
Mar 29, 2020·International Immunopharmacology·Peng CaoYong Zhao
Mar 12, 2021·Stem Cell Research & Therapy·Yi LiYayi Hou

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
PCR
FACS
Assay

Software Mentioned

ModFit LT
SPSS
FlowJo
GraphPad Prism

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.